HRI is a UK-registered charity dedicated to advancing scientific research into homeopathy at an international level. It funds and supports research projects worldwide, publishes evidence summaries covering physicochemical, biological, and clinical studies, and hosts a researcher directory and international conferences.

EFHPA represents patients across Europe who use or seek homeopathic treatment, defending their rights and interests and working towards the integration of homeopathy into EU healthcare policy. It brings together national patient associations from around 18 European countries and lobbies for harmonised implementation of EU directives relevant to homeopathic medicines.

AFHC is a US national consumer organization working to protect access to homeopathic medicines, which are currently under regulatory pressure from the FDA. It advocates for federal legislation—most recently the bicameral Homeopathic Drug Product Safety, Quality and Transparency Act—through grassroots campaigns, congressional outreach, and a broad coalition of homeopathy organizations, manufacturers, and consumers.

The TCIH Coalition is a global non-profit based in Geneva, Switzerland, uniting practitioners, patients, researchers, and Indigenous communities in advancing a person-centred, holistic approach to health. Grown out of the 2022 People’s Declaration for TCIH, it advocates with bodies like the WHO for the recognition and integration of traditional and complementary healthcare into health systems worldwide.

The WHO is the United Nations’ specialized agency for international public health, directing and coordinating global health matters among its member states. It sets health standards, monitors disease outbreaks, and works to expand access to healthcare worldwide, including through its Traditional Medicine Strategy relevant to complementary and integrative health practices.

This WHO Q&A page explains traditional, complementary and integrative medicine (TCIM)—used in 170 countries according to a 2019 WHO report—and outlines WHO’s evidence-based approach to safely integrating it into national health systems. It covers WHO’s Global Traditional Medicine Strategy 2025–2034, patient safety, regulation, and TCIM’s historical contribution to modern medicine.

ECHAMP works to develop the industry for homeopathic and anthroposophic medicinal products so as to ensure availability of both medicines for self-medication and medicines recommended by prescribers. It represents manufacturers on EU policy and legislation, covering areas like the EU Pharmaceutical Strategy, product safety, and manufacturing standards, and publishes research and evidence on the sector.